[The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation]
- PMID: 17502070
- DOI: 10.1051/medsci/2007235526
[The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation]
Abstract
Chronic granulomatous disease (CGD) is a rare inherited disorder in which phagocytes lack NADPH oxidase activity. Patients with CGD suffer from recurrent bacterial and fungal infections because of the absence of superoxide anions (O2- degrees ) generatingsystem. The NADPH oxidase complex is composed of a membranous cytochrome b558, cytosolic proteins p67phox, p47phox, p40phox and two small GTPases Rac2 and Rap1A. Cytochrome b558 consists of two sub-units gp91phox and p22phox. The most common form of CGD is due to mutations in CYBB gene encoding gp91phox. In some rare cases, the mutated gp91phox is normally expressed but is devoided of oxidase activity. These variants called X+ CGD, have provided interesting informations about oxidase activation mechanisms. However modelization of such variants is necessary to obtain enough biological material for studies at the molecular level. A cellular model (knock-out PLB-985 cells) has been developed for expressing recombinant mutated gp91phox for functional analysis of the oxidase complex. Recent works demonstrated that this cell line genetically deficient in gp91phox is a powerful tool for functional analysis of the NADPH oxidase complex activation.
Similar articles
-
[Molecular aspects of chronic granulomatous disease. "the NADPH oxidase complex"].Bull Acad Natl Med. 2007 Feb;191(2):377-90; discussion 390-2. Bull Acad Natl Med. 2007. PMID: 17969555 Review. French.
-
Nicotinamide-adenine dinucleotide phosphate oxidase assembly and activation in EBV-transformed B lymphoblastoid cell lines of normal and chronic granulomatous disease patients.J Immunol. 1998 Nov 1;161(9):4968-74. J Immunol. 1998. PMID: 9794433
-
Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.Hum Genet. 2004 Oct;115(5):418-27. doi: 10.1007/s00439-004-1173-z. Epub 2004 Aug 24. Hum Genet. 2004. PMID: 15338276
-
The search for a genetic defect in Polish patients with chronic granulomatous disease.Arch Immunol Ther Exp (Warsz). 2004 Nov-Dec;52(6):441-6. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15577746
-
Phagocyte NADPH oxidase: a multicomponent enzyme essential for host defenses.Arch Immunol Ther Exp (Warsz). 2005 May-Jun;53(3):199-206. Arch Immunol Ther Exp (Warsz). 2005. PMID: 15995580 Review.
Cited by
-
First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.J Clin Immunol. 2009 Mar;29(2):215-30. doi: 10.1007/s10875-008-9243-y. Epub 2008 Sep 5. J Clin Immunol. 2009. PMID: 18773283
-
Genetics and immunopathology of chronic granulomatous disease.Semin Immunopathol. 2008 Jul;30(3):209-35. doi: 10.1007/s00281-008-0121-8. Epub 2008 May 29. Semin Immunopathol. 2008. PMID: 18509647 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous